Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

E-Z-EM continues with cost-cutting initiative:

This article was originally published in Clinica

Executive Summary

E-Z-EM is to move its powder-based barium production to its manufacturing facility in Montreal as part of its ongoing strategy to streamline its global production infrastructure. Lake Success, New York-based E-Z-EM, who develops contrast agents for gastrointestinal radiology, expects the move to take 12 months to complete and to generate annual pre-tax savings of around $2.2m. The charges incurred will be recorded over a 12-month period and are estimated on a pre-tax basis at $2.8m.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058746

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel